Nourish Raises $100M Series C to Turn Dietitians Into Healthcare Infrastructure
Nourish raised $100M led by Menlo Ventures to scale AI-powered metabolic healthcare, virtual dietitian services, and GLP-1 support.
New York-based Nourish just raised $100M in Series C funding to expand its AI-powered metabolic health platform and nationwide network of registered dietitians. The round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners. Nourish operates an insurance-covered virtual nutrition care platform focused on chronic disease and metabolic health. Founded by Aidan Dewar, Sam Perkins, and Stephanie Liu, the company says it has helped 500k+ people, built a network of 6,000+ dietitians across all 50 states, and enabled 94% of patients to pay $0 out of pocket through insurance coverage.
The funding lands in the middle of a massive healthcare recalibration. GLP-1 medications changed public awareness around obesity and metabolic care almost overnight, but they also exposed a deeper problem inside the healthcare system: medication alone does not build sustainable outcomes. Patients still need behavioral support, nutritional guidance, adherence management, and continuity of care after the prescription is written. That gap created an entirely new infrastructure layer inside healthcare, and Nourish moved into it early.
What Happened
Nourish announced a $100M Series C to expand its AI-native metabolic care platform, grow its clinical network, and deepen partnerships with health plans, employers, and healthcare systems. Bloomberg reported the financing values Nourish at approximately $1.75B, though the company did not formally confirm valuation details. The financing included participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners, signaling continued conviction from investors already familiar with the company’s operating model.
Nourish now has total funding of approximately $215M following prior raises, including a $70M Series B announced in 2025. That progression matters because digital health investors have become significantly more selective over the last 24 months. Capital is no longer flowing toward vague engagement metrics or wellness branding disguised as healthcare infrastructure. Investors increasingly want measurable outcomes, payer alignment, and scalable clinical operations. Nourish checks all 3 boxes.
Why GLP-1 Care Needs Nutrition Infrastructure
The rise of GLP-1 medications fundamentally changed the economics of obesity and metabolic care. Employers are worried about long-term costs. Insurers are trying to determine which care models actually improve outcomes. Healthcare systems are scrambling to support millions of patients entering metabolic treatment pathways without overwhelming already fractured provider networks. Nutrition care suddenly stopped looking optional.
According to the CDC, 6 in 10 U.S. adults live with at least 1 chronic disease, while 4 in 10 live with 2 or more. That reality turns metabolic health into one of the largest operational and financial pressure points in modern healthcare. Nourish built directly into that pressure point. The company connects patients with registered dietitians through insurance-covered virtual care while supporting them between visits with app-based engagement, AI meal tracking, symptom monitoring, educational content, wearable integrations, and coordinated care workflows. Nourish also says it equips providers with AI copilots that automate note-taking and surface clinical insights.
The important detail here is not the AI itself. Every startup deck in America suddenly contains the letters “AI” somewhere between slide 3 and projected revenue fantasy. The real differentiator is workflow integration. Nourish is using AI to reduce friction inside clinical operations instead of trying to replace care relationships entirely. That distinction matters more than the marketing headlines.
How Nourish Makes Money
Digital health companies love talking about “access” until reimbursement enters the conversation and the economics start sweating through their expensive Patagonia vest. Nourish solved a much harder problem than patient acquisition. The company built payer alignment into the center of its business model.
Nourish generates revenue through insurance reimbursement tied to registered dietitian care and healthcare partnerships. According to the company, 94% of patients pay $0 out of pocket because visits are covered through insurance relationships that include Medicare, UnitedHealthcare, Blue Cross Blue Shield plans, Aetna, Cigna, and additional national carriers. That changes the company’s positioning entirely.
Nourish is no longer operating like a wellness app chasing engagement metrics and subscription churn. It behaves more like healthcare infrastructure connected directly into chronic disease management, payer economics, and long-term cost reduction strategies. Healthcare investors understand the distinction immediately. The market already has enough wellness companies selling temporary motivation. What it lacks are scalable systems capable of coordinating longitudinal care across patients, providers, insurers, and metabolic treatment pathways. That’s where Nourish is positioning itself.
The Competitive Landscape Is Shifting Fast
Nutrition care occupied a strange corner of healthcare for years. Clinically important. Financially ignored. Operationally fragmented. That market dynamic is changing quickly.
The combination of GLP-1 adoption, chronic disease costs, employer healthcare pressure, AI-enabled care coordination, and nationwide telehealth infrastructure created an entirely new category sitting between traditional telehealth, metabolic clinics, and preventative healthcare systems. Nourish is building aggressively inside that intersection. The company now operates with 6,000+ dietitians nationwide and publicly frames itself around long-term metabolic health rather than short-term weight-loss cycles. That framing matters strategically because obesity treatment alone is becoming crowded. Sustainable chronic disease management is the much larger opportunity.
The next decade of healthcare will likely reward platforms capable of integrating nutrition support, AI workflows, payer reimbursement, behavioral care, and longitudinal patient engagement into a unified operating layer. That’s the real signal behind this funding round. This is not investors chasing another wellness trend. This is capital moving toward healthcare infrastructure designed around prevention, continuity, operational efficiency, and measurable outcomes. And right now, infrastructure is where the smartest money in healthcare is moving.
Frequently Asked Questions
What is Nourish?
Nourish is a New York-based virtual nutrition care company providing insurance-covered access to registered dietitians focused on chronic disease and metabolic health.
How much funding did Nourish raise?
Nourish raised $100M in Series C funding led by Menlo Ventures.
Who founded Nourish?
Nourish was founded by Aidan Dewar, Sam Perkins, and Stephanie Liu in 2021.
What does Nourish do?
Nourish connects patients with registered dietitians through virtual care while supporting metabolic health, chronic disease management, nutrition counseling, and GLP-1-related care.
How does Nourish make money?
Nourish generates revenue through insurance reimbursement tied to registered dietitian care and healthcare partnerships.
Why are investors interested in metabolic health startups?
Metabolic health startups sit at the intersection of chronic disease management, GLP-1 adoption, payer cost reduction, and preventative healthcare infrastructure.
What role does AI play in Nourish’s platform?
Nourish uses AI tools to support provider workflows, patient engagement, clinical insights, meal tracking, and longitudinal care coordination.
Why does GLP-1 growth matter for Nourish?
GLP-1 adoption increases demand for long-term nutrition support, adherence management, and sustainable metabolic care infrastructure.